Found: 486
Select item for more details and to access through your institution.
Tuberous Xanthoma: A Clue to the Diagnosis of Familial Hypercholesterolemia.
- Published in:
- Indian Journal of Clinical Cardiology, 2024, v. 5, n. 3, p. 298, doi. 10.1177/26324636241227024
- By:
- Publication type:
- Article
Lipid management -- Part 3: Triglycerides and use of non-statin drugs.
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 4, p. 119
- By:
- Publication type:
- Article
In silico comparative analysis of cestode and human NPC1 provides insights for ezetimibe repurposing to visceral cestodiases treatment.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72136-1
- By:
- Publication type:
- Article
Management of Dyslipidemia in the Elderly.
- Published in:
- Journal of Clinical Outcomes Management, 2018, v. 25, n. 7, p. 311
- By:
- Publication type:
- Article
Cost effective prescribing in cardiovascular disease.
- Published in:
- Practice Nursing, 2012, v. 23, n. 10, p. 488, doi. 10.12968/pnur.2012.23.10.488
- By:
- Publication type:
- Article
Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention.
- Published in:
- Wiener Klinische Wochenschrift, 2023, v. 135, n. 23/24, p. 674, doi. 10.1007/s00508-023-02296-z
- By:
- Publication type:
- Article
Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients.
- Published in:
- Wiener Klinische Wochenschrift, 2023, v. 135, n. 13/14, p. 364, doi. 10.1007/s00508-023-02221-4
- By:
- Publication type:
- Article
Effects of Ezetimibe on Endothelial Progenitor Cells and Microparticles in High-Risk Patients.
- Published in:
- Cell Biochemistry & Biophysics, 2014, v. 70, n. 1, p. 687, doi. 10.1007/s12013-014-9973-9
- By:
- Publication type:
- Article
HOW DO WE EFFECTIVELY LOWER LDL-CHOLESTEROL IN HIGH-RISK PATIENTS?
- Published in:
- Acta Marisiensis. Seria Medica, 2024, v. 70, p. 29
- By:
- Publication type:
- Article
Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2024, v. 24, n. 3, p. 419, doi. 10.1007/s40256-024-00642-8
- By:
- Publication type:
- Article
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 5, p. 477, doi. 10.1007/s40256-023-00594-5
- By:
- Publication type:
- Article
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 4, p. 441, doi. 10.1007/s40256-023-00590-9
- By:
- Publication type:
- Article
Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 67, doi. 10.1007/s40256-022-00552-7
- By:
- Publication type:
- Article
Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 395, doi. 10.1007/s40256-021-00516-3
- By:
- Publication type:
- Article
Is it Time for Single-Pill Combinations in Dyslipidemia?
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 239, doi. 10.1007/s40256-021-00498-2
- By:
- Publication type:
- Article
Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 4, p. 381, doi. 10.1007/s40256-020-00421-1
- By:
- Publication type:
- Article
Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies in Regard to Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 4, p. 343, doi. 10.1007/s40256-019-00386-w
- By:
- Publication type:
- Article
Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 3, p. 239, doi. 10.1007/s40256-019-00379-9
- By:
- Publication type:
- Article
Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination.
- Published in:
- American Journal of Cardiovascular Drugs, 2019, v. 19, n. 3, p. 237, doi. 10.1007/s40256-018-00317-1
- By:
- Publication type:
- Article
Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits.
- Published in:
- American Journal of Cardiovascular Drugs, 2018, v. 18, n. 1, p. 65, doi. 10.1007/s40256-017-0247-y
- By:
- Publication type:
- Article
Defining the Place of Ezetimibe/Atorvastatin in the Management of Hyperlipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 3, p. 169, doi. 10.1007/s40256-016-0205-0
- By:
- Publication type:
- Article
LDL-Cholesterol: Standards of Treatment 2016: A German Perspective.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 5, p. 323, doi. 10.1007/s40256-016-0179-y
- By:
- Publication type:
- Article
Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 3, p. 213, doi. 10.1007/s40256-015-0119-2
- By:
- Publication type:
- Article
Add-on Ezetimibe Reduces Small Dense Low-Density Lipoprotein Cholesterol Levels Without Affecting Absorption of Eicosapentaenoic Acid in Patients with Coronary Artery Disease: A Pilot Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2014, v. 14, n. 5, p. 387, doi. 10.1007/s40256-014-0082-3
- By:
- Publication type:
- Article
Role of Colesevelam in Combination Lipid-Lowering Therapy.
- Published in:
- American Journal of Cardiovascular Drugs, 2013, v. 13, n. 5, p. 315, doi. 10.1007/s40256-013-0037-0
- By:
- Publication type:
- Article
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 6, p. 369, doi. 10.2165/11539150-000000000-00000
- By:
- Publication type:
- Article
Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.
- Published in:
- Respirology, 2017, v. 22, n. 3, p. 559, doi. 10.1111/resp.12948
- By:
- Publication type:
- Article
Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1406493
- By:
- Publication type:
- Article
Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.922531
- By:
- Publication type:
- Article
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2605, doi. 10.1111/dom.15146
- By:
- Publication type:
- Article
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2389, doi. 10.1111/dom.13384
- By:
- Publication type:
- Article
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 989, doi. 10.1111/dom.12909
- By:
- Publication type:
- Article
Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1226, doi. 10.1111/dom.12749
- By:
- Publication type:
- Article
The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 6, p. 513, doi. 10.1111/dom.12059
- By:
- Publication type:
- Article
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 7, p. 615, doi. 10.1111/j.1463-1326.2011.01383.x
- By:
- Publication type:
- Article
Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events DIABETES, OBESITY AND METABOLISM.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 11, p. 958, doi. 10.1111/j.1463-1326.2010.01261.x
- By:
- Publication type:
- Article
Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 11, p. 983, doi. 10.1111/j.1463-1326.2010.01289.x
- By:
- Publication type:
- Article
Rebuttal to 'ezetimibe treatment should be considered for patients with sitosterolemia'.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Ezetimibe treatment should be considered for patients with sitosterolemia.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Lipid management -- what's new?
- Published in:
- Practice Nurse, 2016, v. 46, n. 4, p. 12
- By:
- Publication type:
- Article
Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
- Published in:
- Diabetes & Metabolism Journal, 2024, v. 48, n. 3, p. 387, doi. 10.4093/dmj.2024.0168
- By:
- Publication type:
- Article
Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes & Metabolism Journal, 2024, v. 48, n. 1, p. 55, doi. 10.4093/dmj.2023.0442
- By:
- Publication type:
- Article
Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Ezetimibe for Japanese Patients with Dyslipidaemia.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 3, p. 157, doi. 10.2165/11531530-000000000-00000
- By:
- Publication type:
- Article
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1317, doi. 10.1007/s13300-018-0439-8
- By:
- Publication type:
- Article
Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease.
- Published in:
- International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/265305
- By:
- Publication type:
- Article
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives.
- Published in:
- Cardiology Research & Practice, 2020, p. 1, doi. 10.1155/2020/9815016
- By:
- Publication type:
- Article
Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review.
- Published in:
- Nutrients, 2023, v. 15, n. 6, p. 1517, doi. 10.3390/nu15061517
- By:
- Publication type:
- Article
A Review of Low-Density Lipoprotein-Lowering Diets in the Age of Anti-Sense Technology.
- Published in:
- Nutrients, 2023, v. 15, n. 5, p. 1249, doi. 10.3390/nu15051249
- By:
- Publication type:
- Article
Comment on Aaseth et al. Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy. Nutrients 2022, 14 , 2381.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor